Pancreatic islet transplantation can correct the disordered glucose metabol
ism of IDDM, but its widespread application will probably need non-human so
urce of islets. Immunosuppression presently available to control rejection
of xenografts is unsustainable clinically. However, experiments in rodents
suggest that xenogeneic islets can survive without continuing immunosuppres
sion and experiments in large outbred species suggest that clinically appli
cable protocols are possible.